Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
14276
Titan Machinery
TITN
$598M
| $523 | ﹤0.01% |
37
-34,923
| -100% | -$506K |
2021 Q2
14 quarters
|
|
14277
Sera Prognostics
SERA
$82.4M
| $521 | ﹤0.01% |
+64
| New | +$470 |
2024 Q4
0 quarters
|
|
14278
PUT
Codexis
CDXS
$149M
| $477 | ﹤0.01% |
100
| – | – |
2022 Q3
9 quarters
|
|
|
XBPEW
14279
XBP Europe Holdings Warrant
XBPEW
| $475 | ﹤0.01% |
11,866
-403
| -3% | -$14 |
2024 Q3
1 quarter
|
|
|
BCAB
14280
CALL
DELISTED
BIOATLA INC
BCAB
| $473 | ﹤0.01% |
16
+6
| +60% | +$504 |
2021 Q4
12 quarters
|
|
|
LONA
14281
PUT
LeonaBio Inc
LONA
$45.4M
| $469 | ﹤0.01% |
80
-6,720
| -99% | -$37.9K |
2021 Q2
14 quarters
|
|
|
FRGE
14282
PUT
DELISTED
Forge Global Holdings
FRGE
| $465 | ﹤0.01% |
+33
| New | +$544 |
2024 Q4
0 quarters
|
|
|
SLXNW
14283
Silexion Therapeutics Warrant
SLXNW
$31.4K
| $456 | ﹤0.01% |
13,580
-4,825
| -26% | -$194 |
2024 Q3
1 quarter
|
|
|
DFSCW
14284
DEFSEC Technologies Warrant
DFSCW
| $455 | ﹤0.01% |
22,098
+180
| +0.8% | +$4 |
2024 Q1
3 quarters
|
|
14285
PUT
System1
SST
$21.2M
| $449 | ﹤0.01% |
50
+40
| +400% | +$403 |
2024 Q3
1 quarter
|
|
14286
PepGen
PEPG
$158M
| $443 | ﹤0.01% |
+117
| New | +$729 |
2024 Q4
0 quarters
|
|
|
TRVG
14287
PUT
trivago
TRVG
$330M
| $436 | ﹤0.01% |
200
-300
| -60% | -$579 |
2024 Q1
3 quarters
|
|
|
PAVMZ
14288
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
| $425 | ﹤0.01% |
42,892
+200
| +0.5% | +$4 |
2024 Q2
2 quarters
|
|
14289
CALL
Brilliant Earth
BRLT
$23.5M
| $420 | ﹤0.01% |
200
-15,200
| -99% | -$27.9K |
2024 Q1
3 quarters
|
|
|
FTIIW
14290
DELISTED
FutureTech II Acquisition Corp. Warrant
FTIIW
| $418 | ﹤0.01% |
20,675
-321
| -2% | -$7 |
2024 Q2
2 quarters
|
|
14291
CALL
Transact Technologies
TACT
$49.7M
| $409 | ﹤0.01% |
100
| – | – |
2024 Q3
1 quarter
|
|
|
SUP
14292
CALL
DELISTED
Superior Industries International
SUP
| $408 | ﹤0.01% |
200
-100
| -33% | -$252 |
2024 Q2
2 quarters
|
|
|
SOL
14293
PUT
DELISTED
Emeren Group
SOL
| $406 | ﹤0.01% |
+200
| New | +$442 |
2024 Q4
0 quarters
|
|
|
LANV.WS
14294
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
| $402 | ﹤0.01% |
+10,044
| New | +$253 |
2024 Q4
0 quarters
|
|
14295
BRC Group Holdings
RILY
$195M
| $399 | ﹤0.01% |
87
| – | – |
2024 Q3
1 quarter
|
|
14296
PUT
TRX Gold Corp
TRX
$393M
| $399 | ﹤0.01% |
1,300
-4,100
| -76% | -$1.5K |
2024 Q3
1 quarter
|
|
|
SYRS
14297
PUT
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $391 | ﹤0.01% |
1,700
-35,200
| -95% | -$42.3K |
2023 Q4
4 quarters
|
|
14298
Actinium Pharmaceuticals
ATNM
$36.8M
| $375 | ﹤0.01% |
298
+275
| +1,196% | +$427 |
2022 Q1
11 quarters
|
|
|
SNAXW
14299
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
| $363 | ﹤0.01% |
47,733
+1,820
| +4% | +$10 |
2023 Q4
4 quarters
|
|
14300
CALL
Martin Midstream Partners
MMLP
$85.3M
| $359 | ﹤0.01% |
100
-500
| -83% | -$1.98K |
2023 Q3
5 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.